GLOBAL TRAZODONE HYDROCHLORIDE (API) MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024


Report ID : RNR-264797 Category : Pharma Healthcare Published Date : Apr-19
Publisher : Research-N-Reports Pages : 123 Format : PDF

Avail 15% Discount, Use RNR15 Coupon Code.
T&C*

Trazodone, a phenylpiperazine?triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.

Scope of the Report:
Only few manufacturers can produce trazodone hydrochloride (API) in USA. Teva, the Israeli company, has a production base in the United States, dominates the market with the production market share of 92.98% in 2015
The price of trazodone hydrochloride (API) has a overall upward trend from 2011 to 2016, with a little decrease in 2012 and 2015. The average price of trazodone hydrochloride (API) is about 218 USD/Kg in 2015. The average product profit margin is about 55.82% in 2015, and it also experienced fluctuations in recent years. 
The worldwide market for Trazodone Hydrochloride (API) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Trazodone Hydrochloride (API) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Teva
- Angelini
- Mylan
- Fermion
- The Piramal Group

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Trazodone Hydrochloride (API)
- Others

Market Segment by Applications, can be divided into
- Antidepression
- Anxiolytic
- Hypnotic
- Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Trazodone Hydrochloride (API) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Trazodone Hydrochloride (API), with price, sales, revenue and global market share of Trazodone Hydrochloride (API) in 2017 and 2018.
Chapter 3, the Trazodone Hydrochloride (API) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Trazodone Hydrochloride (API) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Trazodone Hydrochloride (API) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Trazodone Hydrochloride (API) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents

1 Market Overview
1.1 Trazodone Hydrochloride (API) Introduction
1.2 Market Analysis by Type
1.2.1 Trazodone Hydrochloride (API)
1.2.2 Others
1.3 Market Analysis by Applications
1.3.1 Antidepression
1.3.2 Anxiolytic
1.3.3 Hypnotic
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Trazodone Hydrochloride (API) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Trazodone Hydrochloride (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Angelini
2.2.1 Business Overview
2.2.2 Trazodone Hydrochloride (API) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Angelini Trazodone Hydrochloride (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Mylan
2.3.1 Business Overview
2.3.2 Trazodone Hydrochloride (API) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mylan Trazodone Hydrochloride (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Fermion
2.4.1 Business Overview
2.4.2 Trazodone Hydrochloride (API) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Fermion Trazodone Hydrochloride (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 The Piramal Group
2.5.1 Business Overview
2.5.2 Trazodone Hydrochloride (API) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 The Piramal Group Trazodone Hydrochloride (API) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Trazodone Hydrochloride (API) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Trazodone Hydrochloride (API) Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Trazodone Hydrochloride (API) Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Trazodone Hydrochloride (API) Manufacturer Market Share in 2018
3.3.2 Top 6 Trazodone Hydrochloride (API) Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Trazodone Hydrochloride (API) Market Analysis by Regions
4.1 Global Trazodone Hydrochloride (API) Sales, Revenue and Market Share by Regions
4.1.1 Global Trazodone Hydrochloride (API) Sales and Market Share by Regions (2014-2019)
4.1.2 Global Trazodone Hydrochloride (API) Revenue and Market Share by Regions (2014-2019)
4.2 North America Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
4.3 Europe Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
4.5 South America Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
5 North America Trazodone Hydrochloride (API) by Country
5.1 North America Trazodone Hydrochloride (API) Sales, Revenue and Market Share by Country
5.1.1 North America Trazodone Hydrochloride (API) Sales and Market Share by Country (2014-2019)
5.1.2 North America Trazodone Hydrochloride (API) Revenue and Market Share by Country (2014-2019)
5.2 United States Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
5.3 Canada Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
5.4 Mexico Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
6 Europe Trazodone Hydrochloride (API) by Country
6.1 Europe Trazodone Hydrochloride (API) Sales, Revenue and Market Share by Country
6.1.1 Europe Trazodone Hydrochloride (API) Sales and Market Share by Country (2014-2019)
6.1.2 Europe Trazodone Hydrochloride (API) Revenue and Market Share by Country (2014-2019)
6.2 Germany Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
6.3 UK Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
6.4 France Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
6.5 Russia Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
6.6 Italy Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
7 Asia-Pacific Trazodone Hydrochloride (API) by Country
7.1 Asia-Pacific Trazodone Hydrochloride (API) Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Trazodone Hydrochloride (API) Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Trazodone Hydrochloride (API) Revenue and Market Share by Country (2014-2019)
7.2 China Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
7.3 Japan Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
7.4 Korea Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
7.5 India Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
8 South America Trazodone Hydrochloride (API) by Country
8.1 South America Trazodone Hydrochloride (API) Sales, Revenue and Market Share by Country
8.1.1 South America Trazodone Hydrochloride (API) Sales and Market Share by Country (2014-2019)
8.1.2 South America Trazodone Hydrochloride (API) Revenue and Market Share by Country (2014-2019)
8.2 Brazil Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
8.3 Argentina Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
8.4 Colombia Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
9 Middle East and Africa Trazodone Hydrochloride (API) by Countries
9.1 Middle East and Africa Trazodone Hydrochloride (API) Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Trazodone Hydrochloride (API) Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Trazodone Hydrochloride (API) Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
9.3 Turkey Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
9.4 Egypt Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
9.5 Nigeria Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
9.6 South Africa Trazodone Hydrochloride (API) Sales and Growth Rate (2014-2019)
10 Global Trazodone Hydrochloride (API) Market Segment by Type
10.1 Global Trazodone Hydrochloride (API) Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Trazodone Hydrochloride (API) Sales and Market Share by Type (2014-2019)
10.1.2 Global Trazodone Hydrochloride (API) Revenue and Market Share by Type (2014-2019)
10.2 Trazodone Hydrochloride (API) Sales Growth and Price
10.2.1 Global Trazodone Hydrochloride (API) Sales Growth (2014-2019)
10.2.2 Global Trazodone Hydrochloride (API) Price (2014-2019)
10.3 Others Sales Growth and Price
10.3.1 Global Others Sales Growth (2014-2019)
10.3.2 Global Others Price (2014-2019)
11 Global Trazodone Hydrochloride (API) Market Segment by Application
11.1 Global Trazodone Hydrochloride (API) Sales Market Share by Application (2014-2019)
11.2 Antidepression Sales Growth (2014-2019)
11.3 Anxiolytic Sales Growth (2014-2019)
11.4 Hypnotic Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Trazodone Hydrochloride (API) Market Forecast (2019-2024)
12.1 Global Trazodone Hydrochloride (API) Sales, Revenue and Growth Rate (2019-2024)
12.2 Trazodone Hydrochloride (API) Market Forecast by Regions (2019-2024)
12.2.1 North America Trazodone Hydrochloride (API) Market Forecast (2019-2024)
12.2.2 Europe Trazodone Hydrochloride (API) Market Forecast (2019-2024)
12.2.3 Asia-Pacific Trazodone Hydrochloride (API) Market Forecast (2019-2024)
12.2.4 South America Trazodone Hydrochloride (API) Market Forecast (2019-2024)
12.2.5 Middle East and Africa Trazodone Hydrochloride (API) Market Forecast (2019-2024)
12.3 Trazodone Hydrochloride (API) Market Forecast by Type (2019-2024)
12.3.1 Global Trazodone Hydrochloride (API) Sales Forecast by Type (2019-2024)
12.3.2 Global Trazodone Hydrochloride (API) Market Share Forecast by Type (2019-2024)
12.4 Trazodone Hydrochloride (API) Market Forecast by Application (2019-2024)
12.4.1 Global Trazodone Hydrochloride (API) Sales Forecast by Application (2019-2024)
12.4.2 Global Trazodone Hydrochloride (API) Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source